Skip to main content

Rolling Action Plan – our chemical evaluations list

The Rolling Action Plan lists our current and recently completed chemical evaluations. The Rolling Action Plan forms part of our approach to protecting human health and the environment.

Decorative image

What is the Rolling Action Plan?

The Rolling Action Plan is our work plan for prioritising chemicals for evaluation, which are selected based on the outcomes of our Evaluation Selection Analysis (ESA) process.

The plan lists our proposed, ongoing and recently completed chemical evaluations. It doesn't include evaluations initiated for chemicals under a current assessment certificate. 

Our Evaluations Roadmap describes our strategic approach to protect human health and the environment by providing information and recommendations about managing the risks that arise from introducing and using industrial chemicals. By prioritising chemicals on the Inventory, our evaluations are more risk-proportionate, timely and targeted.

For each entry, the Rolling Action Plan includes the: 

  • subject of the evaluation – typically the chemical name or chemical group name
  • reason for the evaluation
  • time it takes to do the evaluation
  • focus of the evaluation – chemical identity, and human health or the environment (or both)
  • current status of the evaluation – for example, in progress, public consultation, completed
  • amendments to our list of evaluation candidates.

The publication of the subject, reason and time period within which the evaluation will be conducted satisfies the requirements of the Industrial Chemicals Act 2019  for initiating an evaluation. 

During an Evaluation Selection Analysis (ESA) process we will identify chemicals that may pose a risk to human health and/or the environment. We will also identify chemicals that are unlikely to require further regulation to manage risks based on their human health and environmental hazards and exposures. This will allow us to publish Evaluation Statements for these chemicals and provide the rationale for not undertaking more detailed evaluations.

When do we update the Rolling Action Plan? 

Generally, we will update the Rolling Action Plan after publishing our evaluations. We publish a notice on our website when we update it. 

We will add details of newly initiated evaluations. Other changes to the rolling action plan may include amendments to the: 

  • evaluation subject
  • time it takes to do the evaluation
  • reason for the evaluation

We may need to update the Rolling Action Plan at other times. If we do, we’ll consult with interested parties and publish a notice on our website. These updates can happen for many reasons, including:

  • an adverse event that warrants a chemical evaluation
  • a stakeholder request to evaluate a chemical has been prioritised through ESA process
  • a post-assessment obligation leads to an evaluation
  • we are informed that new information will become available for the chemical that warrants a chemical evaluation

The identified chemicals covered by the subject of the evaluation may change as the evaluation progresses due to new information becoming available.

Completed evaluations remain on the Rolling Action Plan until the next set of evaluations are published. 

Note: Please contact us if you have any information about any chemical listed on the Rolling Action Plan.

The Rolling Action Plan

We publish and maintain 2 lists as part of the Rolling Action Plan. 

  1. List of evaluations that are in progress, currently open for public consultation or recently completed. Each evaluation could be for a single chemical or a group of chemicals.
  2. Downloadable spreadsheet of chemicals that are covered by an evaluation that is in progress, currently open for public consultation, or recently completed. These chemicals can change during the course of the evaluation if new information becomes available.

Recently completed evaluations

ID Subject of evaluation Reason for evaluation Time period for evaluation Focus Status
EVA00042 1H-Imidazole, 1-ethenyl- (N-vinyl imidazole) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00043 1H-Imidazole, 1-methyl- The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00035 2,5-Cyclohexadiene-1,4-dione (p-benzoquinone) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00052 3-Cyclohexene-1-methanol, 2,4,6-trimethyl- (isocyclogeraniol) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00033 Acetylpropionyl and diacetyl The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00057 Benzenepropanol The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00058 Bronopol and bronidox The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment Completed
EVA00029 Butylated hydroxyanisole and related antioxidants The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment Completed
EVA00059 C7-C12 linear alpha-beta unsaturated aldehydes The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00068 Chemicals not considered for in depth evaluation – Not commercially active in Australia An evaluation is required to provide information on the risks to human health and environment 30/06/2022 Health and Environment Completed
EVA00063 Chemicals that are unlikely to require further regulation to manage risks to environment An evaluation is required to provide information on the risks to environment 30/06/2022 Environment Completed
EVA00064 Chemicals that are unlikely to require further regulation to manage risks to human health An evaluation is required to provide information on the risks to human health 30/06/2022 Health Completed
EVA00061 Chlorocresol and chloroxylenol The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment Completed
EVA00028 Isomers of octahydro tetramethyl naphthalenyl ethanone (OTNE) The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment Completed
EVA00011 Lactic acid isomers The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00024 Lead soaps The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment Completed
EVA00065 Linear alkylbenzene sulfonates The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment Completed
EVA00005 Maleic acid The Evaluation Selection Analysis indicated a potential risk to human health 31/12/2021 Health Completed
EVA00013 Maleic acid esters (medium to long chain) The Evaluation Selection Analysis indicated a potential risk to human health 31/12/2021 Health Completed
EVA00012 Maleic acid salts The Evaluation Selection Analysis indicated a potential risk to human health 31/12/2021 Health Completed
EVA00066 Mercaptobenzimidazoles and their zinc salts The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00009 Phenol, 2,4-dichloro- An evaluation is required to provide information on the risks to human health 30/06/2022 Health Completed
EVA00069 Terpenes and terpenoids, sinpine The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00070 Toluenesulfonamides The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed

Evaluations in progress or under public consultation

ID Subject of evaluation Reason for evaluation Time period for evaluation Focus Status Amendments
EVA00021 1,3,5-Triazine-2,4,6-triamine (melamine) New information has become available about risks to human health and environment 30/06/2022 Health and Environment In Progress -
EVA00041 1,4:7,10-Dimethanodibenzo[a,e]cyclooctene, 1,2,3,4,7,8,9,10,13,13,14,14-dodecachloro-1,4,4a,5,6,6a,7,10,10a,11,12,12a-dodecahydro- (Dechlorane Plus) The Evaluation Selection Analysis indicated a potential risk to human health and environment 30/06/2022 Health and Environment In Progress The timeframe for completion of this evaluation has been extended to enable evaluation of a comprehensive long term aquatic toxicity study expected to be completed in May 2022.
EVA00003 1,4-Dioxane New information has become available about risks to human health 30/06/2022 Health In Progress -
EVA00048 1,6-Octadiene, 7-methyl-3-methylene-(Myrcene) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00032 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl- (theophylline) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00080 1-Propanol, 2,2-dimethyl-, tribromo derivative The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00049 1-Propene, 2,3,3,3-tetrafluoro- Information has been provided as a result of the specific information obligations on the terms of the inventory listing 30/06/2022 Health In Progress -
EVA00075 2,5,8,11,14-Pentaoxapentadecane (tetraglyme) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00089 2,5-Furandione, telomer with ethenylbenzene and (1-methylethyl)benzene, hydrolyzed, 3-(dimethylamino)propyl imide, imide with polyethylene-polypropylene glycol 2-aminopropyl Me ether, 2-[(C10-16-alkyloxy)methyl]oxirane-quaternized, benzoates (salts) New information is available about the chemical’s identity. 30/06/2022 Chemical Identity In Progress -
EVA00050 2,7-Naphthalenedisulfonic acid, 3-hydroxy-4-[(4-sulfo-1-naphthalenyl)azo]-, compounds The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00085 2-phenylphenol and salts Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2022 Environment In Progress -
EVA00007 2-Propenamide, N,N-dimethyl- The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00051 2-Propenoic acid, 2-methoxyethyl ester The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00084 4-tert-butylphenol and 4-tert-pentylphenol Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2022 Environment In Progress -
EVA00036 Acetic acid, (4-nonylphenoxy)- The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00071 Benzalkonium halides An evaluation is required to provide information on the risks to human health 30/06/2022 Health In Progress -
EVA00055 Benzene, 1,2,3,4,5-pentachloro- (PeCB) An evaluation is required to provide information on the risks to human health and environment 30/06/2022 Health and Environment In Progress -
EVA00082 Benzene, 1,4-dichloro-2-nitro- (2,5-dichloronitrobenzene) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00079 Benzene, 1-chloro-2-nitro- (2-chloronitrobenzene) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00081 Benzene, 2,4-dichloro-1-nitro- (2,4-dichloronitrobenzene) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00056 Benzene, hexachloro- (HCB) An evaluation is required to provide information on the risks to human health and environment 30/06/2022 Health and Environment In Progress -
EVA00060 Carbamic acid, 1H-benzimidazol-2-yl-, methyl ester (carbendazim) An evaluation or assessment recommended further evaluation of specific issues related to the chemical(s) 30/06/2022 Health and Environment In Progress -
EVA00087 Chemicals not considered for in depth evaluation – Not commercially active in Australia Evaluation is needed to provide information on human health and environmental risks. 30/06/2022 Health and Environment In Progress -
EVA00086 Chemicals that are unlikely to require further regulation to manage risks to environment Evaluation is needed to provide information on environmental risks. 30/06/2022 Environment In Progress -
EVA00088 Chemicals that are unlikely to require further regulation to manage risks to human health Evaluation is needed to provide information on human health risks. 30/06/2022 Health In Progress -
EVA00078 Compounds of dibutyltin The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00076 Compounds of dimethyltin The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00077 Compounds of dioctyltin The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00006 delta-Damascones The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment In Progress -
EVA00074 Dodecylphenols The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00083 Ethanone, 1-(2,3,4,7,8,8a-hexahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulen-5-yl)-, [3R-(3.alpha.,3a.beta.,7.beta.,8a.alpha.)]- (acetyl cedrene) Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2022 Environment In Progress -
EVA00038 Ethylene brassylate and zenolide The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment In Progress -
EVA00017 Exaltone and related macrocyclic musks The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment In Progress -
EVA00062 Glycidyl acrylate and glycidyl methacrylate The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00026 Lead and lead manufacturing byproducts The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment In Progress -
EVA00054 Long-chain alkyl hydroxyethyl imidazolines Evaluation Selection Analysis indicated a potential human health risk. 30/06/2022 Health In Progress Subject updated from 'Alkyl imidazolines' to 'Long-chain alkyl hydroxyethyl imidazolines' to provide greater clarity on chemicals being evaluated.
EVA00040 Musk tibetene and a structural analogue The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment In Progress -
EVA00022 Octanamide, N-Hydroxy- Information has been provided as a result of the specific information obligations on the terms of the inventory listing 30/06/2022 Health In Progress -
EVA00067 Octynoic and nonynoic acid esters The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00053 Phenol, 4,4'-sulfonylbis- (BPS) The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment In Progress -
EVA00025 Phenyl propanaldehydes The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment In Progress -
EVA00073 Siloxanes substituted with 2-methoxyethanol The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health In Progress -
EVA00008 Straight run gas oils An evaluation is required to provide information on the risks to human health 30/06/2022 Health In Progress -
EVA00031 Trimellitates (high molecular weight) An evaluation is required to provide information on the risks to human health 30/06/2022 Health In Progress -

 

Last updated
Was this page helpful?
For broken links or technical issues, please provide as much detail as possible. Do not include your name, email address and other personal or commercially sensitive information.

Keep informed with updates